PeptideDB

sEH inhibitor-4

CAS: F: C27H28Cl2N4O3 W: 527.44

Intensive structural modification resulted in the identification of compound B15 as an effective sEH inhibitor with a va
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Intensive structural modification resulted in the identification of compound B15 as an effective sEH inhibitor with a value of 0.03 ± 0.01 nm, and the presence of soluble epoxide hydrolase (SEH) can reduce inflammation and pain.
Name sEH inhibitor-4
Formula C27H28Cl2N4O3
Molar Mass 527.44
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Tian Y,et al. Synthesis and biological evaluation of new series of benzamide derivatives containing urea moiety as sEH inhibitors. Bioorg Med Chem Lett. 2022 Aug 15;70:128805.